Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Umekawa Kanako"'
Autor:
Suzumura Tomohiro, Kimura Tatsuo, Kudoh Shinzoh, Umekawa Kanako, Nagata Misato, Matsuura Kuniomi, Tanaka Hidenori, Mitsuoka Shigeki, Yoshimura Naruo, Kira Yukimi, Nakai Toshiyuki, Hirata Kazuto
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 568 (2012)
Abstract Background Rash, liver dysfunction, and diarrhea are known major adverse events associated with erlotinib and gefitinib. However, clinical trials with gefitinib have reported different proportions of adverse events compared to trials with er
Externí odkaz:
https://doaj.org/article/b167f471531b4793a2799d3b50f54586
Plasma RANTES, IL-10, and IL-8 levels in non-small-cell lung cancer patients treated with EGFR-TKIs.
Autor:
Umekawa, Kanako1, Kimura, Tatsuo1 kimutats@med.osaka-cu.ac.jp, Kudoh, Shinzoh1, Suzumura, Tomohiro1, Oka, Takako1, Nagata, Misato1, Mitsuoka, Shigeki1, Matsuura, Kuniomi1, Nakai, Toshiyuki1, Yoshimura, Naruo1, Kira, Yukimi2, Hirata, Kazuto1
Publikováno v:
BMC Research Notes. 2013, Vol. 6 Issue 1, p1-8. 8p. 3 Charts, 2 Graphs.
Autor:
Umekawa, Kanako, Kimura, Tatsuo, Kudoh, Shinzoh, Suzumura, Tomohiro, Nagata, Misato, Mitsuoka, Shigeki, Matsuura, Kuniomi, Oka, Takako, Yoshimura, Naruo, Kira, Yukimi, Hirata, Kazuto
Publikováno v:
Osaka City Medical Journal. 59(1):53-60
Background : Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are routinely used to treat advanced non-small cell lung cancer (NSCLC) patients with activated EGFR mutations, and are associated with excellent response and impr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::4dc510b79653715b0aca5d6a83f0060e
https://dlisv03.media.osaka-cu.ac.jp/il/meta_pub/G0000438repository_00306096-59-1-53
https://dlisv03.media.osaka-cu.ac.jp/il/meta_pub/G0000438repository_00306096-59-1-53
Autor:
Nagata, Misato, Kudoh, Shinzoh, Mitsuoka, Shigeki, Suzumura, Tomohiro, Umekawa, Kanako, Tanaka, Hidenori, Matsuura, Kuniomi, Kimura, Tatsuo, Yoshimura, Naruo, Hirata, Kazuto
Publikováno v:
Osaka City Medical Journal. 59(1):45-52
Background : The rate of lung cancer metastasis to the bone is high and skeletal-related events (SREs) decrease the quality of life in many patients. Recently, it was found that a subgroup of patients with non-small cell lung cancer (NSCLC) have spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::e06c939bec83c351bcf55a1bd278f8a7
https://dlisv03.media.osaka-cu.ac.jp/il/meta_pub/G0000438repository_00306096-59-1-45
https://dlisv03.media.osaka-cu.ac.jp/il/meta_pub/G0000438repository_00306096-59-1-45
Autor:
Suzumura, Tomohiro, Kimura, Tatsuo, Kudoh, Shinzoh, Umekawa, Kanako, Nagata, Misato, Tanaka, Hidenori, Mitsuoka, Shigeki, Yoshimura, Naruo, Kira, Yukimi, Hirata, Kazuto
Publikováno v:
Osaka City Medical Journal. 58(1):25-34
Background : Rash, liver dysfunction, and diarrhea are known as adverse events of erlotinib and gefitinib. However, clinical trials with gefitinib have reported different adverse events compared to those with erlotinib. In an in vitro study, cytochro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::3e33624959a9f727324ff3cd22b10cec
https://dlisv03.media.osaka-cu.ac.jp/il/meta_pub/G0000438repository_00306096-58-1-25
https://dlisv03.media.osaka-cu.ac.jp/il/meta_pub/G0000438repository_00306096-58-1-25
Autor:
Mitsuoka, Shigeki, Kudoh, Shinzoh, Kimura, Tatsuo, Yoshimura, Naruo, Tanaka, Hidenori, Suzumura, Tomohiro, Umekawa, Kanako, Nagata, Misato, Ueda, Takako, Hirata, Kazuto
Publikováno v:
Osaka City Medical Journal. 57(2):59-66
Background : Amrubicin (AMR) is an active agent for relapsed small cell lung cancer (SCLC). However, the activity of AMR in refractory relapsed patients is controversial. The objective of this retrospective analysis was to evaluate the efficacy and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::411f2f6ee5b2a8feb14358e80b15042e
https://dlisv03.media.osaka-cu.ac.jp/il/meta_pub/G0000438repository_00306096-57-2-59
https://dlisv03.media.osaka-cu.ac.jp/il/meta_pub/G0000438repository_00306096-57-2-59
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nagata M; Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University., Kimura T, Suzumura T, Kira Y, Nakai T, Umekawa K, Tanaka H, Matsuura K, Mitsuoka S, Yoshimura N, Oka T, Kudoh S, Hirata K
Publikováno v:
Clinical Medicine Insights. Oncology [Clin Med Insights Oncol] 2013; Vol. 7, pp. 31-9. Date of Electronic Publication: 2013 Feb 13.
Autor:
Manabe M; Dept. of Respiratology Medicine, Osaka City University., Mitsuoka S, Umekawa K, Tanaka H, Kimura T, Yoshimura N, Takeda A, Kudoh S, Hirata K
Publikováno v:
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2012 Apr; Vol. 39 (4), pp. 633-5.